KamyaSankarMD

PubMed

• Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort St...
  D'Aiello, A., Owen, D. H., Amin H Nassar, So Yeon Kim, Jacqueline V Aredo, Jamie Feng, Frances Shepherd, Chao Xu, David Kaldas, Jhanelle E Gray, Thomas J Dilling, Joel...> ;Journal of Thoracic Oncology. 2024 Jan 24
• 2 citations
  Pneumonitis After Chemoradiotherapy and Adjuvant Durvalumab in Stage III Non-Small Cell Lung Cancer.
  Donna M Edwards, Kamya Sankar, Aaren Alseri, Ralph Jiang, Matthew Schipper, Sean Miller, Kathryn Dess, Garth W Strohbehn, David A Elliott, Drew Moghanaki, Nithya Ramna...> ;International Journal of Radiation Oncology, Biology, Physics. 2024 Mar 15
• 1 citations
  Immunotherapy and Transarterial Radioembolization Combination Treatment for Advanced Hepatocellular Carcinoma.
  Yee Hui Yeo, Jeff Liang, Marie Lauzon, Michael Luu, Mazen Noureddin, Walid Ayoub, Alexander Kuo, Kamya Sankar, Jun Gong, Andrew Hendifar, Arsen Osipov, Marc L Friedman...> ;The American Journal of Gastroenterology. 2023 Dec 1
• 1 citations
  Recent advances in the management of hepatocellular carcinoma.
  Kamya Sankar, Jun Gong, Arsen Osipov, Steven A Miles, Kambiz Kosari, Nicholas N Nissen, Andrew E Hendifar, Ekaterina K Koltsova, Ju Dong Yang> ;Clinical and Molecular Hepatology. 2024 Jan 1
• 4 citations
  Predictive Biomarkers for Immune-Checkpoint Inhibitor Treatment Response in Patients with Hepatocellular Carcinoma.
  Jun Ho Ji, Sang Yun Ha, Danbi Lee, Kamya Sankar, Ekaterina K Koltsova, Ghassan K Abou-Alfa, Ju Dong Yang> ;International Journal of Molecular Sciences. 2023 Apr 21
• 1 citations
  TOPAZ-1: a new standard of care for advanced biliary tract cancers?
  Matthew I Ebia, Kamya Sankar, Arsen Osipov, Andrew E Hendifar, Jun Gong> ;Immunotherapy. 2023 May 1
• 32 citations
  Intersection of immune and oncometabolic pathways drives cancer hyperprogression during immunotherapy.
  Gaopeng Li, Jae Eun Choi, Ilona Kryczek, Yilun Sun, Peng Liao, Shasha Li, Shuang Wei, Sara Grove, Linda Vatan, Reagan Nelson, Grace Schaefer, Steven G Allen, Kamya San...> ;Cancer Cell. 2023 Feb 13
• 1 citations
  Impact of immune tolerance mechanisms on the efficacy of immunotherapy in primary and secondary liver cancers.
  Kamya Sankar, Ashley N Pearson, Tejaswi Worlikar, Matthew D Perricone, Erin A Holcomb, Mishal Mendiratta-Lala, Zhen Xu, Neil Bhowmick, Michael D Green> ;Translational Gastroenterology and Hepatology. 2023 Jan 1
• 1 citations
  Approach to systemic therapy in advanced hepatocellular carcinoma.
  Kamya Sankar, Jun Gong, Kambiz Kosari, Nicholas N Nissen, Ju Dong Yang> ;Hepatobiliary Surgery and Nutrition. 2022 Dec 1
• 1 citations
  An evaluation of sotorasib for the treatment of patients with non-small cell lung cancer with KRASG12C mutations.
  Garth W Strohbehn, Kamya Sankar, Angel Qin, Gregory P Kalemkerian> ;Expert Opinion on Pharmacotherapy. 2022 Oct 1
• 6 citations
  De-escalating adjuvant durvalumab treatment duration in stage III non-small cell lung cancer.
  Alex K Bryant, Kamya Sankar, Lili Zhao, Garth W Strohbehn, David Elliott, Drew Moghanaki, Michael J Kelley, Nithya Ramnath, Michael D Green> ;European Journal of Cancer. 2022 Aug 1
• 4 citations
  Prognostic and Predictive Role of PD-L1 Expression in Stage III Non-small Cell Lung Cancer Treated With Definitive Chemoradiation and Adjuvant Durvalumab.
  Alex K Bryant, Kamya Sankar, Garth W Strohbehn, Lili Zhao, Victoria Daniel, David Elliott, Nithya Ramnath, Michael D Green> ;International Journal of Radiation Oncology, Biology, Physics. 2022 Jul 15
• 1 citations
  Molecular biomarkers and liquid biopsies in lung cancer.
  Kamya Sankar, Mina Zeinali, Sunitha Nagrath, Nithya Ramnath> ;Seminars in Oncology. 2022 Jul 3
• 23 citations
  The role of biomarkers in personalized immunotherapy.
  Kamya Sankar, Jing Christine Ye, Zihai Li, Lei Zheng, Wenru Song, Siwen Hu-Lieskovan> ;Biomarker Research. 2022 May 18
• 7 citations
  Timing of Adjuvant Durvalumab Initiation Is Not Associated With Outcomes in Stage III Non-small Cell Lung Cancer.
  Alex K Bryant, Kamya Sankar, Garth W Strohbehn, Lili Zhao, David Elliott, Victoria Daniel, Nithya Ramnath, Michael D Green> ;International Journal of Radiation Oncology, Biology, Physics. 2022 May 1
• 21 citations
  Real World Outcomes versus Clinical Trial Results of Durvalumab Maintenance in Veterans with Stage III Non-Small Cell Lung Cancer.
  Kamya Sankar, Alex K Bryant, Garth W Strohbehn, Lili Zhao, David Elliott, Drew Moghanaki, Michael J Kelley, Nithya Ramnath, Michael D Green> ;Cancers. 2022 Jan 26
• 12 citations
  Prognostic and predictive value of neutrophil-to-lymphocyte ratio with adjuvant immunotherapy in stage III non-small-cell lung cancer.
  Alex K Bryant, Kamya Sankar, Garth W Strohbehn, Lili Zhao, David Elliott, Angel Qin, Sarah Yentz, Nithya Ramnath, Michael D Green> ;Lung Cancer. 2022 Jan 1
• 20 citations
  Immunotherapy for ALK-Rearranged Non-Small Cell Lung Cancer: Challenges Inform Promising Approaches.
  Kamya Sankar, Sunitha Nagrath, Nithya Ramnath> ;Cancers. 2021 Mar 23
• 14 citations
  Validation of the American Joint Committee on Cancer Eighth Edition Staging of Patients With Metastatic Cutaneous Melanoma Treated With Immune Checkpoint Inhibitors.
  Jessica Waninger, Vincent T. Ma, Jeremy Skvarce, Zoey Chopra, Alex K. Bryant, Charles S. Mayo, Yilun Sun, Kamya Sankar, Nithya Ramnath, Christopher D. Lao, Jeremy B. S...> ;JAMA Network Open. 2021 Mar 1
• 5 citations
  Non-Pharmacologic Management of Splenomegaly for Patients with Myelofibrosis: Is There Any Role for Splenectomy or Splenic Radiation in 2020?
  Kamya Sankar, Kristen Pettit> ;Current Hematologic Malignancy Reports. 2020 Oct 1
• 47 citations
  Molecular therapeutic targets in non-small cell lung cancer
  Kamya Sankar, Shirish M Gadgeel, Angel Qin> ;Expert Review of Anticancer Therapy. 2020 Jul 7
• 14 citations
  Thrombosis in the Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.
  Kamya Sankar, Brady L. Stein, Raajit K. Rampal> ;Cancer Treatment and Research. 2019 Jan 1
• 8 citations
  Do All Patients With Polycythemia Vera or Essential Thrombocythemia Need Cytoreduction
  Kamya Sankar, Brady L. Stein> ;Journal of the National Comprehensive Cancer Network. 2018 Dec 1
• 17 citations
  Plasma renin activity, response to aliskiren, and clinical outcomes in patients hospitalized for heart failure: the ASTRONAUT trial
  Muthiah Vaduganathan, Baljash Cheema, Erin Cleveland, Kamya Sankar, Haris Subacius, Gregg C. Fonarow, Scott D. Solomon, Eldrin F. Lewis, Stephen J. Greene, Aldo P. Mag...> ;European Journal of Heart Failure. 2018 Apr 1
• 9 citations
  Fluoroquinolone prophylaxis in autologous hematopoietic stem cell transplant recipients.
  Dipenkumar Modi, Hyejeong Jang, Seongho Kim, Kamya Sankar, Abhinav Deol, Lois Ayash, Lawrence G. Lum, Voravit Ratanatharathorn, Richard Manasa, Kendra Mellert, Pranath...> ;Supportive Care in Cancer. 2017 Apr 2
• Join now to see all